Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.16
18.03.24
-
18.03.25
-26.96%
31.03.24

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€59.00
17.03.24
-
17.03.25
24.64%
26.03.24

buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.18
17.03.24
-
17.03.25
-1.78%
30.03.24

Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.71
17.03.24
€5.00
31.01.26
-2.70%
19.03.24

Could be very worthwhile Investment >20% year
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
17.03.24
€16.00
30.06.26
-8.82%
19.03.24

Could be very worthwhile Investment >20% year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.50
16.03.24
€20.00
16.03.25
-8.28%
25.03.24

Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.40
16.03.24
€20.00
05.02.25
9.26%
25.03.24

buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.26
16.03.24
-
-
16.03.24

buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.16
16.03.24
€6.00
16.03.25
-29.70%
02.04.24

Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€0.56
16.03.24
€6.00
05.02.25
21.30%
28.03.24

Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€251.90
16.03.24
€120.00
16.03.25
-3.22%
30.03.24

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€2.22
16.03.24
€4.00
16.03.25
53.15%
30.03.24

EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€4.89
16.03.24
€48.00
16.03.25
-12.06%
30.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.06
15.03.24
-
04.03.25
13.35%
21.03.24

Geron Corp.

Start price
Target price
Perf. (%)
€1.64
14.03.24
-
14.03.25
87.07%
14.03.24

Geron Corp.

Start price
Target price
Perf. (%)
€1.62
13.03.24
-
13.03.25
82.36%
15.03.24

Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€245.10
13.03.24
-
13.03.25
2.77%
17.03.24

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€62.04
13.03.24
-
13.03.25
-4.90%
16.03.24

buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€252.10
13.03.24
-
13.04.24
-12.53%
14.04.24

buy
Geron Corp.

Start price
Target price
Perf. (%)
€1.68
12.03.24
-
12.03.25
81.49%
15.03.24

Could be very worthwhile Investment >20% year
buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€245.20
12.03.24
-
12.03.25
2.73%
17.03.24

buy
Geron Corp.

Start price
Target price
Perf. (%)
€1.88
12.03.24
-
12.03.25
62.13%
17.03.24

buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€235.80
08.03.24
-
08.03.25
6.83%
17.03.24